AS
Therapeutic Areas
Epitopoietic Research Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Gliovac/ERC1671/SITOIGANAP | Recurrent Glioblastoma Multiforme (GBM) | Phase 2 |
| Platform Expansion | Other Solid Tumors (e.g., SCLC, Pancreatic) | Pre-clinical/Research |
| Infectious Disease Vaccine | SARS-CoV-2, Ebola | Research |